News Articles and Montana BioScience Alliance Newsletters
Fifty-three high school graduates from across Montana have been selected for their effort and potential as the eighth class of Montana State University’s Hilleman Scholars Program, which is named after Maurice Hilleman, one of the state’s most influential native sons and an MSU graduate.
In July, Genentech, a biotechnology company, awarded a $180,000 unrestricted grant to Messengers for Health to promote health equity.
The Galien Foundation has recognized the significant contributions of the Wolf Creek, MT company in the “Best Medical Technology” category.
Milestone marks transition of Inimmune Corporation to a clinical-stage company.
A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented.
Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.
The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.
The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Tuesday, September 5, 2023.
The panel’s decision moves the U.S. one step closer to making jabs against respiratory syncytial virus available to the public this fall, when the disease typically begins to spread at higher levels.
The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.